Synthesis of 4-alkyl (aryl)-6-aryl-3-cyano-2(1H)-pyridinones and their 2-imino isosteres as nonsteroidal cardiotonic agents

被引:56
作者
Abadi, A
Al-Deeb, O
Al-Afify, A
El-Kashef, H
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Dept Pharmacol, Riyadh 11451, Saudi Arabia
来源
FARMACO | 1999年 / 54卷 / 04期
关键词
cardiotonics; milrinone analogues; 2(1H)-pyridinones;
D O I
10.1016/S0014-827X(99)00004-X
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Thirty new 1,2-dihydropyridine derivatives of the general formula 4-alkyl (aryl)-6-aryl-3-cyano-2(1H)-pyridinones (1-15) and 4-alkyl (aryl)-6-aryl-3-cyano-2(1H)-iminopyridines (16-30) were synthesized using one-pot multicomponent reactions of the properly substituted acetophenone, appropriate aldehyde, ammonium acetate and ethyl cyanoacetate (1-15) or malononitrile (16-30) in ethanol. These target compounds (1-30) were evaluated for their cardiotonic activity using the spontaneously beating atria model, from reserpine-treated guinea pigs. The best pharmacological profile was obtained with 3-cyano-6-(3,4-dimethoxyphenyl)-4-(4-hydroxyphenyl)-2(1H)-pyridinone (9) which displayed selectivity for increasing the force of contraction (108.7 +/- 6.7,% change over control) rather than the frequency rate (40.81 +/- 5.3,% change over control) at a 5 x 10(-4) M concentration. The effects of structural changes upon activity are reported. (C) 1999 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 25 条
[1]
EFFECTS OF SEVERAL NEWER CARDIOTONIC DRUGS ON CARDIAC CYCLIC-AMP METABOLISM [J].
AHN, HS ;
EARDLEY, D ;
WATKINS, R ;
PRIOLI, N .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (07) :1113-1121
[2]
CARDIOTONIC ACTIVITY OF MILRINONE, A NEW AND POTENT CARDIAC BIPYRIDINE, ON THE NORMAL AND FAILING HEART OF EXPERIMENTAL-ANIMALS [J].
ALOUSI, AA ;
CANTER, JM ;
MONTENARO, MJ ;
FORT, DJ ;
FERRARI, RA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :792-803
[3]
ATTIA A, 1982, PHARMAZIE, V37, P551
[4]
PHYSIOLOGIC ASSESSMENT OF THE INOTROPIC, VASODILATOR AND AFTERLOAD REDUCING EFFECTS OF MILRINONE IN SUBJECTS WITHOUT CARDIAC DISEASE [J].
BOROW, KM ;
COME, PC ;
NEUMANN, A ;
BAIM, DS ;
BRAUNWALD, E ;
GROSSMAN, W .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (09) :1204-1209
[5]
HEART-FAILURE - PATHO-PHYSIOLOGY AND TREATMENT [J].
BRAUNWALD, E .
AMERICAN HEART JOURNAL, 1981, 102 (03) :486-490
[6]
Dömling A, 1998, COMB CHEM HIGH T SCR, V1, P1
[7]
A PHARMACOLOGICAL, CRYSTALLOGRAPHIC, AND QUANTUM-CHEMICAL STUDY OF NEW INOTROPIC AGENTS [J].
DORIGO, P ;
GAION, RM ;
BELLUCO, P ;
FRACCAROLLO, D ;
MARAGNO, I ;
BOMBIERI, G ;
BENETOLLO, F ;
MOSTI, L ;
ORSINI, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (17) :2475-2484
[8]
DORIGO P, 1994, FARMACO, V49, P19
[9]
ANTAGONISM TOWARDS ENDOGENOUS ADENOSINE AND INHIBITION OF CGI-PDE IN THE CARDIAC EFFECTS OF AMRINONE, MILRINONE AND RELATED ANALOGS [J].
DORIGO, P ;
GAION, RM ;
BELLUCO, P ;
BOREA, PA ;
GUERRA, L ;
MOSTI, L ;
FLOREANI, M ;
CARPENEDO, F .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1992, 23 (03) :535-541
[10]
ERHARDT PW, 1988, MOL PHARMACOL, V33, P1